Appili Therapeutics Inc. (APLI.TO)

CAD 0.04

(16.67%)

Long Term Debt Summary of Appili Therapeutics Inc.

  • Appili Therapeutics Inc.'s latest annual long term debt in 2023 was 875.2 Thousand CAD , down -88.41% from previous year.
  • Appili Therapeutics Inc.'s latest quarterly long term debt in 2024 Q1 was 850.3 Thousand CAD , down -2.85% from previous quarter.
  • Appili Therapeutics Inc. reported annual long term debt of 7.55 Million CAD in 2022, up 54.66% from previous year.
  • Appili Therapeutics Inc. reported annual long term debt of 4.88 Million CAD in 2021, up 415.48% from previous year.
  • Appili Therapeutics Inc. reported quarterly long term debt of 875.2 Thousand CAD for 2023 Q4, down -88.47% from previous quarter.
  • Appili Therapeutics Inc. reported quarterly long term debt of 7.64 Million CAD for 2023 Q2, up 2.36% from previous quarter.

Annual Long Term Debt Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Long Term Debt of Appili Therapeutics Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 875.2 Thousand CAD -88.41%
2022 7.55 Million CAD 54.66%
2021 4.88 Million CAD 415.48%
2020 947.3 Thousand CAD -0.34%
2019 950.5 Thousand CAD -10.81%
2018 1.06 Million CAD -2.01%
2017 1.08 Million CAD 152.93%
2016 430 Thousand CAD 0.0%

Peer Long Term Debt Comparison of Appili Therapeutics Inc.

Name Long Term Debt Long Term Debt Difference
Eupraxia Pharmaceuticals Inc. - CAD -Infinity%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 6.37 Million CAD 86.282%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. - CAD -Infinity%
Oncolytics Biotech Inc. 290 Thousand CAD -201.793%
Sernova Corp. - CAD -Infinity%